What is BioCatch?
Founded in 2011 and headquartered in Israel, BioCatch provides a sophisticated platform that develops behavioral biometric profiles of online users. By analyzing unique human interactions—such as mouse movements, typing cadence, and device orientation—the company effectively distinguishes between legitimate users and non-human cybersecurity threats. This technology serves as a cornerstone for modern fraud prevention, particularly within the fintech and banking sectors, where maintaining seamless user experiences while ensuring robust security is paramount. BioCatch's market position is reinforced by its ability to integrate into existing digital ecosystems, providing a passive, continuous authentication layer that operates without disrupting the user journey.
How much funding has BioCatch raised?
BioCatch has raised a total of $213.1M across 6 funding rounds:
Other Financing Round
$600K
Other Financing Round
$1M
Unspecified
$6.5M
Series A
$10M
Series B
$30M
Series C
$165M
Other Financing Round (2012): $600K with participation from JANVEST Capital Partners
Other Financing Round (2013): $1M led by JANVEST Capital Partners
Unspecified (2014): $6.5M supported by JANVEST Technologies and OurCrowd
Series A (2014): $10M featuring Blumberg Capital and OurCrowd
Series B (2018): $30M backed by CreditEase, OurCrowd, American Express, JANVEST Capital Partners, and Kreos Capital
Series C (2020): $165M with participation from CreditEase, National Australia Bank, Barclays, Citibank, Bain Capital Tech Opportunities, American Express, Maverick ventures, and HSBC
Key Investors in BioCatch
OurCrowd
Founded in 2013, OurCrowd is a company that offers an investment platform built for accredited investors and institutions to invest in startups, early-stage companies, and venture funds.
JANVEST Capital Partners
Joule Ventures is a first-check fund that supports Israeli founders in commercializing enterprise-grade solutions within U.S. markets, focusing on sectors like Cyber Security and Fintech.
American Express
American Express operates as a global financial services organization specializing in payment solutions and travel services, maintaining a strategic interest in innovative fintech security.
What's next for BioCatch?
As BioCatch moves beyond its Series C milestone, the strategic focus is expected to shift toward global expansion and the deepening of its enterprise-grade security capabilities. The involvement of major financial institutions in its recent funding rounds suggests a roadmap centered on deeper integration within the global banking infrastructure. Future growth will likely be driven by the adoption of its behavioral biometric technology across new verticals, including e-commerce and government services, where the demand for frictionless identity verification is accelerating. By maintaining its commitment to R&D, BioCatch is well-positioned to address the evolving landscape of AI-driven cyber threats, ensuring its platform remains at the forefront of digital identity protection.
See full BioCatch company page
